Prio Wealth Limited Partnership Boston Scientific Corp Transaction History

Prio Wealth Limited Partnership

$3.38 Billion
Q3 2024

A detailed history of Prio Wealth Limited Partnership transactions in Boston Scientific Corp stock. As of the latest transaction made, Prio Wealth Limited Partnership holds 725,424 shares of BSX stock, worth $77 Million. This represents 1.8% of its overall portfolio holdings.

Number of Shares

725,424

Previous 754,443 3.85%

Holding current value

$77 Million

Previous $58.1 Million 4.63%

% of portfolio

1.8%

Previous 1.75%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$72.96 - $84.0 $2.12 Million - $2.44 Million	-29,019 Reduced 3.85%	725,424 $60.8 Million
Q2 2024 Sep 10, 2024	SELL	$67.33 - $77.71 $6.42 Million - $7.41 Million	-95,373 Reduced 11.22%	754,443 $58.1 Million
Q1 2024 May 14, 2024	BUY	$57.6 - $68.62 $3.18 Million - $3.79 Million	55,167 Added 6.94%	849,816 $58.2 Million
Q4 2023 Jan 22, 2024	SELL	$48.64 - $57.81 $929,802 - $1.11 Million	-19,116 Reduced 2.35%	794,649 $45.9 Million
Q3 2023 Oct 31, 2023	SELL	$50.19 - $54.68 $3.09 Million - $3.36 Million	-61,480 Reduced 7.02%	813,765 $43 Million
Q2 2023 Aug 08, 2023	SELL	$49.72 - $54.64 $10.9 Million - $12 Million	-220,076 Reduced 20.09%	875,245 $47.3 Million
Q1 2023 May 12, 2023	SELL	$45.09 - $50.03 $1.03 Million - $1.14 Million	-22,733 Reduced 2.03%	1,095,321 $54.8 Million
Q4 2022 Feb 13, 2023	SELL	$39.56 - $47.22 $1.66 Million - $1.98 Million	-41,982 Reduced 3.62%	1,118,054 $0
Q3 2022 Feb 27, 2023	BUY	$36.71 - $109.66 $406,636 - $1.21 Million	11,077 Added 0.97%	1,154,745 $44.7 Million
Q2 2022 Feb 27, 2023	BUY	$35.24 - $47.1 $902,637 - $1.21 Million	25,614 Added 2.29%	1,143,668 $42.6 Million
Q1 2022 Feb 21, 2023	BUY	$40.9 - $45.1 $2.25 Million - $2.49 Million	55,105 Added 4.93%	1,173,159 $52 Million
Q4 2021 Feb 17, 2022	BUY	$38.07 - $44.87 $297,517 - $350,659	7,815 Added 0.68%	1,160,036 $49.3 Million
Q3 2021 Nov 12, 2021	BUY	$41.23 - $45.88 $673,450 - $749,403	16,334 Added 1.44%	1,152,221 $50 Million
Q2 2021 Aug 16, 2021	SELL	$38.58 - $44.24 $9,027 - $10,352	-234 Reduced 0.02%	1,135,887 $48.6 Million
Q1 2021 May 06, 2021	BUY	$35.27 - $39.67 $1.9 Million - $2.13 Million	53,731 Added 4.96%	1,136,121 $43.9 Million
Q4 2020 Feb 04, 2021	BUY	$33.15 - $41.97 $409,170 - $518,035	12,343 Added 1.15%	1,082,390 $38.9 Million
Q3 2020 Nov 16, 2020	BUY	$34.44 - $42.23 $672,303 - $824,371	19,521 Added 1.86%	1,070,047 $40.9 Million
Q2 2020 Aug 11, 2020	BUY	$30.19 - $39.11 $724,167 - $938,131	23,987 Added 2.34%	1,050,526 $36.9 Million
Q1 2020 May 13, 2020	SELL	$25.83 - $45.71 $117,629 - $208,163	-4,554 Reduced 0.44%	1,026,539 $33.5 Million
Q4 2019 Feb 10, 2020	BUY	$37.87 - $45.37 $427,438 - $512,091	11,287 Added 1.11%	1,031,093 $46.6 Million
Q3 2019 Nov 13, 2019	SELL	$40.31 - $43.45 $296,238 - $319,314	-7,349 Reduced 0.72%	1,019,806 $41.5 Million
Q2 2019 Jul 18, 2019	SELL	$34.91 - $42.98 $65,630 - $80,802	-1,880 Reduced 0.18%	1,027,155 $44.1 Million
Q1 2019 May 03, 2019	SELL	$32.91 - $40.75 $480,848 - $595,398	-14,611 Reduced 1.4%	1,029,035 $39.5 Million
Q4 2018 Feb 06, 2019	SELL	$31.73 - $39.04 $107,659 - $132,462	-3,393 Reduced 0.32%	1,043,646 $36.9 Million
Q3 2018 Nov 07, 2018	BUY	$32.83 - $38.63 $1.1 Million - $1.29 Million	33,407 Added 3.3%	1,047,039 $40.3 Million
Q2 2018 Aug 06, 2018	SELL	$26.84 - $34.32 $501,210 - $640,891	-18,674 Reduced 1.81%	1,013,632 $33.1 Million
Q1 2018 Apr 17, 2018	BUY	$25.2 - $28.54 $26 Million - $29.5 Million	1,032,306 New	1,032,306 $28.2 Million

Others Institutions Holding BSX

# of Institutions

1,655

Shares Held

1.22B

Call Options Held

8.72M

Put Options Held

9.6M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $152B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prio Wealth Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Prio Wealth Limited Partnership with notifications on news.

Account

Prio Wealth Limited Partnership Boston Scientific Corp Transaction History